Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that targeting 5α-reductase, the androgen receptor, and hair growth genes, along with using compounds with anti-androgenic properties, could lead to more effective hair loss treatments.

DHT affects hair follicle cells by changing microRNA levels, leading to less cell growth and more cell death.

Finasteride negatively affects fish reproduction and gonadal development.

The mouse model suggests male pattern baldness may be due to an enzyme increasing DHT and higher androgen receptor levels in hair follicles.

Only minoxidil and finasteride are FDA-approved for hair loss, with other treatments available but less effective or with side effects.

Finasteride increases hair count and improves hair growth with low risk of side effects.

Clascoterone cream is a safer, effective acne treatment with fewer side effects.

Targeting androgen receptors in the skin is the most effective treatment for hyperandrogenism-related skin issues.

Solanum nigrum extract may help regrow hair.

BLIMP1 is essential for skin maintenance but not for defining sebaceous gland progenitors.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

New hormonal treatments for enlarged prostate show promise for safer, effective non-surgical options.

Growth factors and cytokines are important for hair growth and could potentially treat hair loss, but more research is needed to overcome challenges before they can be used in treatments.

Hormones and metabolism play a complex role in prostate enlargement, and more research is needed to improve diagnosis and treatment.

Acne treatment varies, with topical and systemic therapies effective, and more research needed on treatment order and long-term effects.

Treatment with plasma rich in growth factors improved hair density and thickness for hair loss patients.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

Acne is caused by genetics, diet, hormones, and bacteria, with treatments not yet curative.

Certain gene variants may contribute to high androgen levels in women with polycystic ovary syndrome.

The review suggests thorough evaluation and genetic testing for proper diagnosis and treatment of Chrousos syndrome.

The document concludes that new treatments are needed to better manage acne and reduce side effects related to current therapies.

Lack or blocking of SRD5a, a key component in hormone creation, can lead to conditions like pseudohermaphrodism and affect hair growth, bone mass, muscle strength, and reproductive health. More research is needed on its regulation from fertilization to adulthood.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Hormones and genes affect hair growth and male baldness.

Micrografts promote hair growth in androgenetic alopecia treatment.

New cell-based therapies may improve hair loss treatments in the future.

The article explains how to identify and treat excessive hair growth in women, which can be distressing and may signal other health problems.

Analog 23 is a promising compound for prostate cancer treatment.

Knowing how skin works and its diseases helps doctors diagnose and treat skin conditions better.

Skin problems in PCOS, like excess hair, acne, and hair loss, may not always indicate high male hormone levels and need careful diagnosis for proper treatment.